New Webinar: Non-Industry Voices on THR & Vaping Products

For many decades, since the long-term effects and risks of consuming conventional tobacco products became known, tobacco harm reduction, or THR, has been a main area of focus for many leading organizations—both governmental and non-governmental.

Prior to the advent of the electronic cigarette and vaping products, tobacco harm reduction efforts generally revolved around the taxation, labeling, and packaging of conventional tobacco products. However, with the rising popularity and emergence of the vaping industry over the past few years, the focus should now be shifted to help support and promote less harmful nicotine delivery alternatives to smoking.

Watch as Patricia Kovacevic, Nicopure Labs’ General Counsel and Chief Compliance Officer shares selected opinions and statements about the role of vaping products in tobacco harm reduction (THR) from organizations and individuals outside of the vaping industry.

ABOUT NICOPURE LABS
Nicopure Labs is an industry-leading manufacturer of premium, American-made e-liquids: Halo, eVo, and Purity.

CONNECT WITH NICOPURE LABS

https://www.nicopure.com/
https://www.halocigs.com/
https://www.facebook.com/nicopurelabs
https://www.linkedin.com/company/nicopurelabs
https://twitter.com/NicopureLabs

Previous How to Avoid a Dry Hit
Next 5 Ways to Cool Off with your Vape

About author

You might also like

Halo News 0 Comments

Halo Retailer Spotlight: Magic Vapor Shop of London, KY

Jerry Wayne, CEO of Magic Vapor Shop, started selling vaping products in a parking lot before the cold chased him indoors. Now he owns six bustling stores … Halo: Where

Halo News 3 Comments

Nicopure Labs Challenges the FDA’s Deeming Rule

May 10, 2016 — TAMPA, FL — Nicopure Labs, LLC, the leading manufacturer of American-made e-liquids was the first to file suit in the U.S. District Court for the District

Halo News 0 Comments

Patricia Kovacevic’s Webinar on the FDA’s Deeming Rule

If you missed Halo General Counsel Patricia Kovacevic’s webinar on the FDA’s upcoming Deeming Rule, you can watch it in its entirety right here. Ms. Kovacevic covered the basics of